Shanghai, China — Up to June 26, over 1000 robot-assisted surgeries have been performed in urology, hepatobiliary surgery, gastrointestinal surgery, thoracic surgery, obstetrics and gynecology, breast and thyroid surgery and other departments of more than 40 hospitals in 20 provinces across the country by using Toumai® four-arm laparoscopic surgical robot (Toumai® robot for short) of Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot® for short) in strict accordance with research ethics, covering difficult and complex procedures such as pelvic, abdominal, and thoracic surgeries. Among them, over 500 surgeries have been conducted from January to June in 2023, creating the new record for number of robot-assisted laparoscopic surgeries in China. Experience of 1000 surgeries indicates that Toumai® robot has good clinical suitability, and is becoming a well established technology in clinical application. It can fully meet the clinical requirements of multiple departments, help doctors continue to challenge and successfully complete difficult surgeries, and help the hospital continuously achieve high-quality development in clinical and scientific research.

 

Toumai® Laparoscopic Surgical Robot

 

In December 2022, a Toumai® Laparoscopic Surgical Robot, the first four-arm laparoscopic surgical robot approved by NMPA for marketing, had been sold and installed for commercial use. With the naked eye 3D high-definition view, and high degree of freedom artificial wrist, Toumai® robot can provide doctors with a very realistic surgical experience and eye-hand-mechanical synchronization, demonstrating a leading technology among Chinese robots.

 

After marketing, Toumai® robot assists Chinese top experts in urology, hepatobiliary and pancreatic surgery, thoracic surgery, gastrointestinal surgery, obstetrics and gynecology and other areas to continuously challenge difficult surgeries, broaden its application in clinical surgeries. It is used not onlyin the classic surgical surgeries in the field of urology, including radical prostatectomy, nephrectomy, partial nephrectomy, adrenalectomy, ureteral bladder reimplantation, and other difficult procedures, but also in general surgery, thoracic surgery, and gynecological surgery, the first among Chinese robots.

 

These include dozens of Chinese robot-assisted high-difficulty surgeries, such as the first Chinese robot-assisted radical prostatectomy, the first Chinese robot-assisted single-port surgery, the first Chinese robot-assisted partial nephrectomy, the first Chinese robot-assisted radical resection for lung cancer, the first Chinese robot-assisted radical gastrectomy, and the first Chinese robot-assisted radical nephrectomy, the first Chinese robot-assisted liver resection, the first Chinese robot-assisted hysterectomy, the first Chinese robot-assisted colon cancer radical surgery, the first 5G ultra-remote robot-assisted urological surgery, the first 5G remote robot-assisted gastric cancer radical surgery, the first 5G ultra-remote robot-assisted hepatobiliary surgery, the first 5G ultra-remote robot-assisted gynecological surgery, and the first 5G ultra-remote robot-assisted lobectomy in animal experiment.

 

In addition, a series of difficult surgeries have been completed in many hospitals with assistance of Tumai® robots, indicating its routine use in clinical surgeries. Among them, 5 distal pancreatectomy surgeries have been completed in pancreatic surgery department of Ruijin Hospital of Shanghai Jiaotong University School of Medicine; 32 surgeries have been completed in the Fourth Hospital of Hebei Medical University; 50 surgeries have been completed in the First Affiliated Hospital of Zhengzhou University; 50 clinically validated surgeries have been completed in obstetrics and gynecology department of the Second Hospital of Dalian Medical University; 50 urinary system tumor surgeries have been completed in Shanghai Changhai Hospital; 50 surgeries have been completed in the Affiliated Provincial Hospital of Shandong First Medical University; 70 surgeries have been completed in People's Hospital of Xinjiang Uygur Autonomous Region; 72 surgeries have been completed in the urology department of First Affiliated Hospital of Zhejiang University School of Medicine.

 

During the successful completion of these difficult surgeries, Toumai® was continuously optimized according to suggestions from clinicians, so as to bring better experience for surgeons.

 

Experience of 1000 surgeries, as a major milestone, not only provides a significant scientific basis for important clinical research and theoretical practice, filling in the gaps in relevant fields in China, but also fully verifies the indications, clinical utility, operation convenience, stability and innovation of Toumai®.

 

Indications and clinical utility of Toumai® robot verified through difficult surgical procedures

Toumai® robot was granted a registration certificate in January 2022 by NMPA for urology surgeries, and became the first four-arm laparoscopic surgical robot developed by Chinese companies and approved for marketing.

 

In addition, confirmatory clinical trials of Toumai® robot used in general surgery, thoracic surgery and gynecological endoscopic surgery has been completed in April 2022, covering multiple first robot-assisted or difficult surgeries in the above fields, thus filling in the gaps in clinical use of Chinese robots. Toumai® robot also became the world second, and the Chinese first laparoscopic surgery robot that is indicated for important and complex surgical procedures in the fields of thoracic, abdominal, and pelvic surgery.

Urology

01

 

On November 1, 2019, Yinghao Sun, academician of Changhai Hospital, completed a Robot-Assisted Laparoscopic Radical Prostatectomy (RALRP for short) with Toumai® robot in Shanghai Dongfang Hospital. This is the first success RALRP assisted by Chinese robots, and Toumai® robot is the first Chinese laparoscopic surgery robot that finished difficult urology surgery, demonstrating that Chinese laparoscopic surgery robots can also be used in similar difficult and complex surgeries.

02

 

In December 2020, Professor Dahong Zhang, the research leader of Urology department and Associate Director of Zhejiang Provincial People's Hospital, completed the first Chinese robot-assisted laparoscopic partial nephrectomy with Toumai® robot.

03

 

In December 2020, the first Chinese robot-assisted retroperitoneal partial nephrectomy had been successfully completed by a team led by Professor Jianming Guo, director of urology department of Zhongshan Hospital of Fudan University. It is another significant break-through for Toumai® in the clinical field of difficult and complex urology.

04

 

In December 2020, the first Chinese robot-assisted extraperitoneal radical prostatectomy had been successfully completed by a team led by Professor Jianming Guo, Shuai Jiang and Zhibing Xu of urology department of Zhongshan Hospital of Fudan University.

05

 

In December 2020, Professor Dahong Zhang, the research leader of Urology department and Associate Director of Zhejiang Provincial People's Hospital, completed the first Chinese robot-assisted single-port laparoscopic partial nephrectomy (single-port RAPN) with Toumai® four-arm laparoscopic surgical robot.

06

 

In December 2020, a partial nephrectomy of entirely endophytic renal tumor had been successfully completed by Professor Wei Xue and Jiahua Pan of Ren Ji Hospital of Shanghai Jiao Tong University School of Medicine, with the assistance of Toumai® robot.

07

 

In March 2022, a team led by Professor Linghong Song of Xinjiang Kizilsu People's Hospital successfully completed single-port laparoscopic high ligation of left spermatic vein assisted by Toumai® robot. In addition, the first robot-assisted adrenal tumor resection, cystolithectomy, and right nephrolithotomy were completed by team members (Jie Yang, Yunqiang Shao, Jinyong Tian and Elias), indicating a new era of robot-assisted surgery in XinJiang Uygur Autonomous Region.

08

 

In September 2022, the first Chinese robot-assisted radical resection of left renal carcinoma with renal venous tumor thrombus using Toumai® robot was completed by a team led by Professor Lingwu Chen, director of urology department of the First Affiliated Hospital of Sun Yat-sen University. Within half a month from mid-September (the installation date of Toumai® robot) to September 30, 12 difficult surgeries had been finished in the First Affiliated Hospital of Sun Yat-sen University.

09

 

In November 2022, the first four-arm laparoscopic surgical robot-assisted retroperitoneal radical nephrectomy had been successfully completed by a team led by Dan Xia and Su Wang, directors of urology department of the First Affiliated Hospital of Zhejiang University School of Medicine. According to available data, Toumai® is the first Chinese robot used in this difficult, challenging and high-risk surgery. This is also the 5th complex difficult surgery with Toumai® finished within 2 weeks after the installation of Toumai® in the First Affiliated Hospital of Zhejiang University School of Medicine. Toumai® robot has been installed in the First Affiliated Hospital of Zhejiang University School of Medicine in October 16, and used in the first surgery in October 25. Three difficult and complex surgeries had been finished with Toumai® on the same day in October 27. Five difficult surgeries had been completed by a team led by directors Dan Xia and Su Wang within 1 week, including 3 cases of extraperitoneal radical prostatectomy, 1 case of retroperitoneal partial nephrectomy, and 1 case of intraperitoneal radical resection of left renal carcinoma + paraaortic lymph node dissection.

10

 

In November 2022, the first Chinese robot-assisted total endovenous radical cystectomy + in situ neobladder was finished with Toumai® in China by a team led by Professors Su Wang and Ping Wang of urology department of the First Affiliated Hospital of Zhejiang University School of Medicine. It is a top level urology surgery, as it was performed in the abdominal cavity throughout a cumbersome, complex and difficult procedure.

11

 

In December 2022, a “one-position” radical resection of renal pelvis carcinoma assisted by Toumai® was succefully completed by a team led by Professor Su Wang of urology department of the First Affiliated Hospital of Zhejiang University School of Medicine. The radical resection of renal pelvis carcinoma involves kidneys, perirenal fat sac, hilar lymph nodes, full length of ureter, characterized by wide range of resection, and long tumor diameter on the vertical axis, etc.. This success case is another attempt of Toumai® in difficult surgery, indicating that it can be used routinely in difficult and complex surgeries in the field of urology.

12

 

In December 2022, 2 cases of difficult radical prostatectomy had been finished with the assistance of Toumai® by a team led by Dan Xia and Su Wang, directors of urology department of the First Affiliated Hospital of Zhejiang University School of Medicine. One of them is extraperitoneal “intrafascial” radical prostatectomy, and the other is intraperitoneal radical prostatectomy.

13

 

In April 2023, a robot-assisted radical nephrectomy with inferior vena cava thrombectomy was successfully completed with Toumai® by the team of Professor Xuepei Zhang in the Department of Urology of the First Affiliated Hospital of Zhengzhou University. Featured by high risk, large amount of blood loss and great challenge to the surgeon, this surgery is known as the "crown jewel" of urological surgery. It is a new memorable milestone as this is also the first case of Chinese robot-assisted minimally invasive urological surgery with high difficulty.

14

 

In April 2023, the first robot-assisted pediatric urological surgery was successfully finished with Toumai® robot in Sanya Maternal and Child Health Hospital of Shanghai Children's Medical Center Affiliated to School of Medicine, Shanghai Jiaotong University. It is the first Toumai® Robot-assisted pediatric urological surgery in China, marking the beginning of the application of Toumai® Robot to a wider range of patient groups, and making a breakthrough in reaching the southern region of the national clinical medical business - the southernmost province of China.

15

 

In April 2023, Professor Jiuzhi Li, and Dr. Xun Li of the Urological Surgery Center of the People's Hospital of Xinjiang Uygur Autonomous Region successfully completed a difficult ureteral bladder replantation with the assistance of the Toumai®.

Obstetrics and gynecology

01

 

In November 2021, the first Chinese robot-assisted total hysterectomy plus double appendectomy was successfully completed using Toumai® by the team of Professor Lipin Cai, Director of obstetrics and gynecology department of the First Affiliated Hospital of Nanchang University.

02

 

In December 2021, a Toumai® robot-assisted total hysterectomy plus double appendectomy was finished by the team of Professor Keqin Hua of Obstetrics and Gynecology Hospital of Fudan University. As is the first Toumai® robot-assisted gynecological surgery, it further verifies that Toumai® can be used in gynecological surgery, urological surgery, thoracic surgery, hepatobiliary surgery, gastrointestinal surgery, and other chest, abdomen, and pelvic surgeries.

03

 

In December 2021, a Toumai® robot-assisted total hysterectomy was completed in the Fourth Hospital of Harbin Medical University by the team of Professor Honghui Zhao, Director of obstetrics and gynecology, known as the first Chinese surgical robot-assisted gynecological surgery in confirmatory clinical trial.

 

In January 2022, a safety and efficacy clinical trial of Toumai® robot in gynecological surgery was successfully completed by cooperation of Professor Keqin Hua of Obstetrics and Gynecology Hospital of Fudan University, Professor Honghui Zhao of the Fourth Hospital of Harbin Medical University, and Professor Lipin Cai of the First Affiliated Hospital of Nanchang University. This is the second field of clinical application of Toumai® after the completion of confirmatory clinical trial of Toumai® in urological surgery. Therefore, Toumai® became the first Chinese laparoscopic surgical robot that had been undergone the confirmatory clinical trial in the field of pelvic surgery.

04

 

In October 2022, the first Toumai® robot-assisted comprehensive staging laparotomy of endometrial cancer (high abdominal aortic lymphadenectomy at the level of left renal vein), type C2 radical hysterectomy of cervical cancer and comprehensive staging laparotomy of early ovarian cancer was finished by the team of Director Jun Wang and Professor Shichao Han of obstetrics and gynecology department of the Second Hospital of Dalian Medical University. It is a “top level” Gynecologic Oncology surgery in the field of gynecologic oncology due to its difficulty. The development of this clinical scientific research project not only filled the historical gap in the clinical scientific research project of large-scale high-end medical device in the Second Hospital of Dalian Medical University, but also marked that Toumai®, as a Chinese high-performance medical device, has reached the world's advanced level.

Gastrointestinal surgery

01

 

In November 2021, the first Chinese four-arm laparoscopic surgical robot-assisted Laparoscopic Sleeve Gastrectomy was successfully completed with Toumai® by the team of Professor Yuntao Ma of general surgery department of Gansu Provincial Hospital.

02

 

In December 2021, 2 cases of Toumai® robot-assisted surgery were finished successively by the team of Professor Hongliang Yao, Director of gastrointestinal surgery department of the Second Xiangya Hospital of Central South University, including a radical gastrectomy and a radical surgery of sigmoid colon cancer. This radical gastrectomy is also the first Toumai® Laparoscopic Surgical Robot-assisted radical gastrectomy in southern region of China.

03

 

In December 2021, a robot-assisted radical resection of right colon cancer via medial approach was successfully completed with Toumai® by Professor Taiyuan Li, Director of general surgery department of the First Affiliated Hospital of Nanchang University. It is the first Chinese laparoscopic surgical robot-assisted radical resection of right colon cancer in eastern region of China, and an another important break-through in clinical application of Toumai® in the field of difficult and complex general surgery, after the first Chinese laparoscopic surgical robot-assisted radical surgery of sigmoid colon cancer.

Hepatobiliary surgery

01

 

In December 2021, the first Chinese surgical robot-assisted choledochoscopic cholecystectomy and common bile duct stone removal in China was finished with Toumai® by the team of Professor Lishan Xu of oncological surgery and hepatobiliary surgery department of the Fourth Hospital of Harbin Medical University.

02

 

In January 2022, a Toumai® robot-assisted liver resection was finished by the team of Professor LiShan Xu of oncological surgery and hepatobiliary surgery department of the Fourth Hospital of Harbin Medical University. It is the first Chinese surgical robot-assisted liver resection in northeast region of China, and an another Toumai® robot-assisted difficult hepatobiliary surgery after robot-assisted choledochoscopic cholecystectomy and common bile duct stone removal by Professor Lishan Xu.

03

 

In January 2022, a Toumai® robot-assisted liver resection was finished in Sir Run Run Shaw Hospital of Zhejiang University Medical School, indicating that all surgery cases were successfully finished in the confirmatory clinical trial of this site. Under the guidance of Xiujun Cai, director of the Hospital, the confirmatory clinical trial of Toumai® was conducted smoothly. During the trial, the team of Professor Xiao Liang of general surgery department successfully finished the first Chinese robot-assisted left lateral hepatectomy in eastern region of China, and set up a record of 3 surgeries in one day, fully demonstrating that Toumai® can be used in clinical procedures with high difficulty and high intensity.

04

 

In January 2022, the last two hepatectomy surgeries assisted by Toumai® robot were sucessfully completed by the team of Professor Yuntao Ma of general surgery department of Gansu Provincial Hospital. At this point, Toumai® had been successfully used in all surgical cases in this multidisciplinary and multicenter confirmatory clinical trial, and became the world second and the Chinese first laparoscopic surgical robot indicated for important and complex surgical procedures in the fields of thoracic, abdominal, and pelvic surgery, demonstrating that Chinese laparoscopic surgical robots are fully capable of difficult and complex surgery in many fields, laying an important foundation for the marketization of Chinese high-end medical devices.

Thoracic Surgery

01

 

In October 2021, a difficult right lower lobectomy in clinical trial was successfully finished with the assistance of Toumai® by the team of Professor Yunjiu Gou in thoracic surgery department of Gansu Provincial Hospital.

02

 

In November 2021, a Toumai® robot-assisted thoracoscopic partial left lower lung resection was successfully completed by the team of Professor Bentong Yu, Director of thoracic surgery department of the First Affiliated Hospital of Nanchang University. It is the first Chinese laparoscopic surgical robot-assisted thoracic surgery in southern region that further verifies the safety and efficacy of Toumai® in thoracic surgery, indicating that Toumai® surgical robot entered extensive and in-depth clinical application stage in the fields of thoracic surgery, hepatobiliary surgery, gastrointestinal surgery, urology and gynecology.

03

 

In November 2021, the first robot-assisted thoracoscopic lobectomy in eastern region and 3 surgeries in clinical trial afterwards were successfully completed with Toumai® by the team of Professor Qingquan Luo of Shanghai Chest Hospital, establishing a record of 4 cases of Chinese surgical robot-assisted thoracoscopic surgery (RATS) finished on the same day of initiaion of Toumai® study.

04

 

In December 2021, one Toumai® robot-assisted mediastinal tumor resection was successfully finished by Professor Qingquan Luo of Shanghai Chest Hospital, in which complete tumor resection and thorough removal of anterior mediastinal fat were achieved. At this point, surgery cases of confirmatory clinical trial were first finished in Shanghai Chest Hospital.

 

In January 2022, the clinical trial of safety and efficacy of Toumai® in thoracic surgery was successfully completed. This trial was jointly conducted by Professor Qingquan Luo of Shanghai Chest Hospital, Professor Bentong Yu of the First Affiliated Hospital of Nanchang University, Professor Jinzhi Xu of the Fourth Hospital of Harbin Medical University, Professor Yunjiu Gou of Gansu Provincial Hospital. Therefore, Toumai® became the first Chinese laparoscopic surgical robot that had been undergone the confirmatory clinical trial in the field of thoracic surgery.

Thyroid breast surgery

01

 

In October 2022, the first Toumai® robot-assisted thyroid cancer radical surgery was finished with high quality and high efficiency by the team of Professor Shijian Yi, Executive Director of thyroid breast surgery department and Associate Director of South China Hospital of Shenzhen University.

Pancreatic surgery

01

 

In October 2022, the first Chinese robot (Toumai®)-assisted pancreatic tumor resection in Shandong province was successfully completed by the team of Professor Bin Jin, Associate Director of the Second Hospital of Shandong University. It is another break-through after the first Toumai® robot-assisted liver and biliary surgery in Shandong, and is of great significance to rapidly improve the clinical application of robot-assisted surgery in China.

02

 

In November 2022, the first Toumai® robot-assisted warshaw operation (a technique in which the important organs of the patient were preserved) in China was successfully completed by the hepatobiliary surgery team of Professor Bin Jin, chief Physician and Associate Director of the Second Hospital of Shandong University. This is another important break-through after the first Toumai® robot-assisted pancreatic tumor resection in Shandong province was completed in the Second Hospital of Shandong University in October 10.

03

 

In March 2023, 5 cases of pancreas body and tail resection were successfully completed with the assistance of Toumai® in Ruijin Hospital of Shanghai Jiaotong University School of Medicine, indicating that Toumai® robot surgical system can be used in clinical pancreatic surgery. Going forward, the Pancreatic Surgery Department of Ruijin Hospital will complete 15 cases of distal pancreatectomies and 5 cases of other pancreatic surgeries, and will become the first tertiary hospital in China to complete pancreatic surgery with a large sample of the Toumai®robotic surgery system.

 

Stability of robot verified in high-intensive surgery

With the further implementation of clinical trial, more and more Toumai® robot-assisted difficult surgeries were successfully conducted, continually establishing the new records of “4 successive surgeries”, “5 successive surgeries”, “6 successive surgeries”. It indicates that Toumai® robot-assisted surgeries are becoming routine operation with high intensity, meeting the clinical requirements to provide better medical services with higher quality for patients.

Successive surgeries

01

 

In January 2023, in the First Affiliated Hospital of Zhengzhou University, the team of chief surgeon Professor Xuepei Zhang and Assistant Doctors Peng Li, Zhaowei Zhu and Yunlong Liu successively completed four difficult cases of urology surgery with the assistance of Toumai®: robot-assisted laparoscopic radical resection of right ureteral carcinoma, robot-assisted laparoscopic partial nephrectomy, robot-assisted retroperitoneal tumor resection, robot-assisted laparoscopic radical resection of left ureteral carcinoma. These surgeries are the first 4 Toumai® robot-assisted surgeries in Hehan province, setting up a record of 4 Toumai® robot-assisted surgeries in a day. In the face of high-intensity "continuous operations", Toumai®has demonstrated its excellent efficiency and stability comparable to imported surgical robots.

02

 

In February 2023, Professor Xuepei Zhang completed 5 Toumai® robot-assisted difficult urological surgeries in a day, breaking his own record of 4 successive surgeries in a day.

03

 

At the end of May 2023, 6 Toumai® Robot-assisted urological surgeries were successfully complated in the People's Hospital of Xinjiang Uygur Autonomous Region, thereby Toumai® became the first Chinese surgical robot achieving “6 consecutive surgeries in a day”. The surgery was performed by three doctors, director Jiuzhi Li, director Zecheng Ni, and deputy director Yong Luo of the urology department. All six surgeries were performed through a lumbar approach, where a narrow surgical space required a high operation capability for the robot in the narrow space.

 

Innovativeness of robot verified by ultra-remote surgeries

Even the advanced technologies require constant innovation. How to promote innovation on the basis of new generation information technology is a hurdle in front of hospitals. Nowadays, with breakthrough in core technologies such as 5G remote control and large-capacity image remote real-time transmission, Toumai® can minimize the delay of images and controls, enable 5G remote surgery with communication distance of more than 5000km, and achieve the functions of real-time monitoring and early warning of network communication quality, to ensure the safe and successful completion of the surgery. This allows hospitals to successfully jump over the said hurdle.

 

Up to now, after strict and sufficient technical verification, animal experiments, and scientific and ethical demonstration, Toumai® Robot and other Robots of MicroPort® MedBot® have assisted medical staff in multiple locations to complete dozens of 5G-based remote surgeries. MicroPort® MedBot® is by now the surgical robot company that has successfully completed remote clinical surgeries in most departments (including urology, thoracic surgery, hepatobiliary surgery, pancreatic surgery, gastrointestinal surgery, and orthopedics) with its product worldwide. The successive “first cases” are not only a major breakthrough in medical field of China, but also a strong proof that Chinese 5G technology and medical device technology are already at the forefront of the world.

Animal experiment

01

 

In September 2022, the team of Professor Yuntao Ma of general surgery department of Gansu Provincial Hospital, in coordination with Shanghai MicroPort MedBot (Group) Co., Ltd. and China Telecom Gansu Branch, hold a serial of Toumai® robot-assisted 5G remote surgeries in animals in Gansu Provincial, named“Silk Road Light”. Durying the activity, 5 robot-assisted 5G remote surgeries in animals were performed in Lanzhou New District Branch of Gansu Provincial Hospital, Wuwei Cancer Hospital, Jiayuguan Hospital of Traditional Chinese Medicine, Jiuquan People's Hospital, Jinta County People's Hospital, demonstrating the stability of Chinese surgical robots and superiority of China Telecom’s 5G technology.

02

 

In March 2023, the first robot-assisted 5G remote online animal surgery for thoracic surgery in China was completed using Toumai®. This surgery was conducted by Professor Qingquan Luo of Shanghai Chest Hospital, with the cooperation of Deputy Chief Physician Jia Huang, attending physician Jiantao Li, attending physician Long Jiang, Dr. Yu Tian, Dr. Hongda Zhu and Director of Anesthesiology Yaofeng Shen. It is the first successful breakthrough of Toumai® Robot in thoracic surgery after completing 5G remote robotic surgeries in hepatobiliary surgery, gastrointestinal surgery and urological surgery.

03

 

In June 2023, Professor Qingquan Luo of Shanghai Chest Hospital, successfully completed the first animal experiment of robot-assisted lobectomy across Shanghai and Xinjiang in China using Toumai® robot system. The success of this experiment signifies Chinese-developed robot-assisted thoracic surgery technology may go beyond the limitations of space and geography, expanding the application of surgical regions and "extending" thousands of miles away, allowing more patients to receive quality medical services.

5G remote surgery

01

 

In June 2022, 2 Toumai® robot-assisted 5G ultra-remote urological surgeries were successfully completed by Linghong Song, Director of Xinjiang Kizilsu People's Hospital, and the team of Director Yang jie (Linghong Song, Jie Yang, Jie Li, Yunqiang Shao, Jinyong Tian), through 5G connection between Xinjiang Kizilsu People's Hospital and Jiangsu Provincial People's Hospital These 2 surgeries crossed over 5000 kilometers from the east to the west of China, ranked the longest-distance robot-assisted 5G remote surgeries worldwide to date.

02

 

On the morning of February 2023, Toumai® robot successfully completed China's first robot-assisted ultra-remote 5G hepatobiliary surgery, creating a miracle in the history of hepatobiliary surgery in China. The surgery crossed the territory of 5000 kilometers. It was performed remotely by Xiao Liang, a chief physician of prof. Xiujun Cai's team of General Surgery Department of Sir Run Run Shaw Hospital of Zhejiang University, with Zheyong Li, deputy medical director and director of General Surgery Department of Aral Hospital and Sir Run Run Shaw Hospital of Zhejiang University, leading the team on site.

03

 

In May 2023, under the guidance of Professor Hui Cai, Director of Gansu Provincial Hospital, 2 Toumai® robot-assisted remote cholecystectomy were operated in operating room of new district branch by the team of Professor Yuntao Ma of Clinical Study Site, General Surgery Department of Gansu Provincial Hospital, for 2 patients with gallstones in Gansu Provincial Hospital located 70 kilometers away from the operation room. It also showed a perfect combination of 5G remote technology with Chinese surgical robots.

04

 

In May 2023, the first Toumai® robot-assisted 5G remote gastric cancer radical surgery was successfully completed by team of Professor Yuntao Ma of Clinical Study Site, General Surgery Department of Gansu Provincial Hospital, with the China Telecom 5G network connection between Gansu Provincial Hospital and its new district branch, achieving a new break-through in 5G remote robot-assisted gastrointestinal surgery.

05

 

In June 2023, the first robot-assisted ultra-remote 5G hepatobiliary surgery worldwide was successfully completed with Toumai® robot, creating a miracle in the history of hepatobiliary surgery in China and the world. The surgery was performed remotely by Xiao Liang, primary surgeon and chief physician, and other team members of professor Xiujun Cai of General Surgery Department of Sir Run Run Shaw Hospital of Zhejiang University, with the on-site cooperation of the team led by Zheyong Li, deputy medical director and director of General Surgery Department of Aral Hospital and Sir Run Run Shaw Hospital of Zhejiang University, and Yuxin Fan, deputy Director of General Surgery Department.

06

 

In June 2023, the first laparoscopic surgical robot-assisted 5G ultra-remote hysterectomy + bilateral adnexectomy + bilateral salpingectomy in the world was finished using Toumai® and with 5G ultra remote connection between the Seventh Medical Center of PLA General Hospital and People's Hospital of Xinjiang Guma County. This surgery was finished jointly by the team led by Yuanguang Meng and Lian Li, Directors of Department of Obstetrics and Gynecology of the Seventh Medical Center, and the team of Obstetrics and Gynecology Department and Operating Room of People's Hospital of Xinjiang Guma County. It is another great break-through of Toumai® robot-assisted complex surgery, and demonstrates the development and application of 5G remote surgery in China.

Toumai® single-arm laparoscopic surgical robot

01

 

In December 2021, the First-in-Man (FIM) trial of single-port laparoscopic robot-assisted cholecystectomy in China had been completed jointly by the team of Professor Zhongtao Zhang of Beijing Friendship Hospital of Capital Medical University and the team of Professor Xun Li of the First Hospital of Lanzhou University. The robot used in this trial is Toumai® Single-Arm Laparoscopic Surgical Robot, which was jointly developed by MicroPort® MedBot® and the team of Professor Zhongtao Zhang and relevant units. This is a major progress in the "13th Five-Year" national key research and development project hold by Professor Zhongtao Zhang. In addition, it indicates success application of Chinese single-arm laparoscopic surgical robot in gastrointestinal surgery, and the success completion of first-in-man trial of Chinese single-arm laparoscopic surgical robot.

02

 

In November 2022, the first Laparoscopic right renal cyst fenestration assisted by Toumai® single-arm surgical robot was completed by Gangyue Hao, Director of urology department of Beijing Friendship Hospital. It was another break-through after more than 10 Toumai® single-arm robot-assisted general surgeries successfully completed by the team led by Zhongtao Zhang, Director of Beijing Friendship Hospital, and Wei Guo, Director of general surgery department of Beijing Friendship Hospital. It indicates that Toumai® single-arm robot’s technical stability and safety have been further verified, laying a strong clinical foundation for further promoting routine application of Toumai® single-arm robot in urology surgeries.

03

 

In March 2023, Professor Liping Cai's team from the Department of Obstetrics and Gynecology of the First Affiliated Hospital of Nanchang University successfully completed the hysterectomy, and successfully extended the clinical application of Toumai® single-arm laparoscopic surgical robot to the field of gynecological hysterectomy. This is the first time that Toumai®Single-arm has been applied to gynecological clinical surgery, demonstrating the core strength of Toumai® Single-arm in the field of gynecological clinical application. Such achievements show that the Chinese-developed surgical robot represented by Toumai® Single-arm is constantly pioneering and innovating, giving full play to its own advantages, expanding achievable surgical methods, and bringing good news to female patients.

04

 

In March 2023, Professor Xiaojun Liu of Obstetrics and Gynecology Department of Shanghai Changzheng Hospital completed 2 surgeries in a day using Toumai® Single-arm Laparoscopic Surgical Robot. The surgeries were all done with a single incision, leveing fewer wounds, which can better meet the patients' pursuit of faster recovery. The first use of Toumai® Laparoscopic Surgical Robot for gynecological surgery in Shanghai Changzheng Hospital is a important break-through, indicating that Shanghai Changzheng Hospital provides patients with high-quality, efficient and patient-oriented medical and health services by continuously improving medical level, and Toumai® single-arm robot can be used in gynecological surgery, especially minimally invasive surgery.

05

 

In March 2023, the clinical trial enrollment of Toumai® single-arm endoscopic surgical robot was officially initiated in the First Affiliated Hospital of Nanchang University. On the day of the launch, two urologic surgeries were performed, namely, Toumai® single-arm robot-assisted adrenal pheochromocytoma resection by retroperitoneal single-site laparoscopic approach and Toumai® single-arm robot-assisted transumbilical single-port laparoscopic resection of duplex kidney and duplicated ureter. Both cases were performed by Prof. Gongxian Wang's team, including Prof. Gongxian Wang, Director Cheng Zhang and Dr. Wei Huang of the Department of Urology in the First Affiliated Hospital of NCU. Single-arm robot is the one of the most difficult surgical robots to develop. Compared with the similar products in other countries, Chinese surgical robots show a very fast update in terms of algorithms, instruments, and have made rapid progress.

06

 

In April 2023, the first Chinese single-arm robot-assisted urology surgery in Shanghai was successfully completed with Toumai® Single-Arm Laparoscopic Surgical Robot in Shanghai Changzheng Hospital. The surgery was a cyst decortication of the left kidney performed by Shancheng Ren, Director of the Department of Urology of Shanghai Changzheng Hospital, which took only 15 minutes. The separation, resection and electrocoagulation operations were performed by the Toumai®single-arm robot, and the process went smoothly.

Dr. Chao He, the president of MicroPort^® MedBot^® Group stated:

Laparoscopic surgical robots are the perfect combination of technological innovation and humanistic care, and are being accepted by more and more patients. The completion of 1000 clinically verified Toumai® robot-assisted surgeries are both a new achievement and a new starting point. It will drive us towards a new journey. MicroPort® MedBot® will, as always, strengthen scientific and technological innovation, personnel training and market cooperation, and continuously enhance the company's value and influence. We hope that our surgical robot technology will reach new heights and bring more benefits to patients by precise, efficient and safe surgical solutions.